https://www.zacks.com/stock/news/2257857/will-low-patient-days-impact-community-health-cyh-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257857
Apr 18, 2024 - Community Health's (CYH) first-quarter results are likely to reflect declining beds in services and adjusted admissions.
zc:-3742342984205416799
0
https://www.zacks.com/stock/news/2257849/bio-rad-laboratories-bio-to-post-q1-earnings-what-awaits?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257849
Apr 18, 2024 - The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
zc:3120196327926588848
0
https://www.zacks.com/stock/news/2257726/edwards-lifesciences-ew-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2257726
Apr 18, 2024 - Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:242527518149851865
0
https://www.zacks.com/stock/news/2257013/is-a-beat-likely-for-edwards-lifesciences-ew-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257013
Apr 17, 2024 - The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.
zc:-3160825256171413185
0
https://www.zacks.com/stock/news/2256354/is-a-beat-likely-for-intuitive-surgical-isrg-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256354
Apr 16, 2024 - Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.
zc:1981100304867191731
0
https://www.zacks.com/stock/news/2256331/unitedhealth-group-unh-tops-on-q1-earnings-reaffirms-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2256331
Apr 16, 2024 - UnitedHealth Group (UNH) first-quarter earnings benefit from strong Optum and UnitedHealthcare business lines. Rising expenses partially offset the positives.
zc:-5145192463365374898
0
https://www.zacks.com/stock/news/2256315/align-technology-algn-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256315
Apr 16, 2024 - Align Technology's (ALGN) first-quarter 2024 performance is likely to reflect the strength of the Clear Aligner and Systems & Services businesses.
zc:-6759002973481477594
0
https://www.zacks.com/stock/news/2256237/itgr-vs-ew-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2256237
Apr 16, 2024 - ITGR vs. EW: Which Stock Is the Better Value Option?
zc:2469286396615588305
0
https://www.zacks.com/stock/news/2256177/what-s-in-store-for-boston-scientific-bsx-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256177
Apr 16, 2024 - Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.
zc:-6457106060917456620
0
https://www.zacks.com/stock/news/2255600/what-s-in-store-for-thermo-fisher-tmo-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2255600
Apr 15, 2024 - Strength in Analytical Instrument and Laboratory Products and Services segments are likely to have driven Thermo Fisher's (TMO) first-quarter 2024 performance.
zc:3981072332015869995
0